Sue Ward - Publications

Journal articles

Conference proceedings papers

  • Richards P, Ward S, Morgan J, Francis M, Collins K, Burton M, Nettleship A, Lifford K, Reed M & Wyld L (2015) Bridging The Age Gap in Breast Cancer - improving treatment decisions for older women using routine data. EUROPEAN JOURNAL OF CANCER CARE, Vol. 24 (pp 62-62)
  • Morgan J, Richards P, Ward S, Lawrence G, Francis M, Collins K, Reed M & Wyld L (2015) The effect of dementia on the treatment of older women with breast cancer in England. FUTURE ONCOLOGY, Vol. 11(4) (pp 13-13)
  • Richards P, Ward S, Morgan J, Francis M, Lawrence G & Wyld L (2015) Age, and not comorbidity, is associated with adjuvant chemotherapy use in older breast cancer patients in England. FUTURE ONCOLOGY, Vol. 11(4) (pp 20-21)
  • Rafia R & Ward SE (2014) Approaches Used to Model the Relationship Between Progression-Free Survival (PFS) / Time-To-Progression (TTP) And Overall Survival (OS) Within Health Economic Models of Cancer Therapies. Value in Health, Vol. 17(7) (pp A557-A557)
  • Rafia R, Ward SE, Scope A & Wyld L (2013) EVALUATING THE COST EFFECTIVENESS OF GENE EXPRESSION PROFILING AND IMMUNOHISTOCHEMISTRY TESTS. VALUE IN HEALTH, Vol. 16(7) (pp A413-A413)
  • Nagy B, Gray L & Ward SE (2012) COST-EFFECTIVENESS ANALYSIS OF THREE YEAR VERSUS ONE YEAR IMATINIB FOR THE TREATMENT OF PATIENTS AT HIGH RISK OF DISEASE RECURRENCE FOLLOWING SURGICAL RESECTION OF KIT (CD117) POSITIVE GASTROINTESTINAL STROMAL TUMOURS (GIST). ANNALS OF ONCOLOGY, Vol. 23 (pp 235-236)
  • Hummel S, Snowden J, Nield A, McGoldrick R, Harrison S, Swanborough F, Davis J, Goddard Y, Ward S, Ezaydi Y, Morley N, Downes T, Wright J & Dalley C (2012) Predicting increases in bed capacity for haematopoietic stem cell transplantation or intensive chemotherapy through simulation modelling of ambulatory care. BONE MARROW TRANSPLANTATION, Vol. 47 (pp S278-S278)
  • Peasgood T, Ward SE & Brazier J (2011) HEALTH STATE UTILITY VALUES IN BREAST CANCER: A REVIEW AND META-ANALYSIS. VALUE IN HEALTH, Vol. 14(7) (pp A462-A462)
  • Meng Y, Ward SE, Cooper K, Harnan SE & Wyld L (2011) THE POTENTIAL ROLE OF MAGNETIC RESONANCE IMAGING (MRI) IN AXILLARY NODE ASSESSMENT OF EARLY BREAST CANCER: AN ECONOMIC EVALUATION. VALUE IN HEALTH, Vol. 14(7) (pp A253-A253)
  • Meng Y, Ward S, Cooper K, Harnan S & Wyld L (2010) Cost-effectiveness assessment of pet and mri for the evaluation of axillary lymphnode metastases in breast cancer: A discrete event simulation model. Proceedings of the 2010 Operational Research Society Simulation Workshop, SW 2010 (pp 49-58)
  • Jewitt K, Pilgrim H & Ward S (2008) A cost-utility analysis of nilotinib for CML patients who have become resistant to imatinib. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 141 (pp 38-38)
  • Pilgrim H, Jewitt K & Ward S (2007) A cost-utility analysis of nilotinib for CML patients who have become resistant to imatinib.. BLOOD, Vol. 110(11) (pp 376B-376B)
  • Bansback N, Ara R, Ward S, Anis A & Choi H (2006) Using economic methods to efficiently design clinical trials: A case study of statin therapy in patients with rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, Vol. 54(9) (pp S534-S535)
  • Bansback N, Ara R, Ward S, Anis A & Choi H (2006) Statin therapy for patients with rheumatoid arthritis: A cost effectiveness analysis. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 98-98)
  • Brennan A, Ward S & Hummel S (2002) Costing the impact of the cancer service guidance. Journal of Clinical Excellence, Vol. 4(1 SUPPL.) (pp 209-210)